Head and Neck Cancer Multivariate Blood Data

Data for the September 2021 submission to eLife. This is the source data for multivariate regression. Progression free survival outcome. Blood samples from 56 HNSCC patients were prospectively obtained within a Phase 2 clinical trial (NCT02633800), before and after the first treatment cycle of platinum-based chemotherapy, to identify biological covariates predictive of outcome. The baseline dataset contained 42 covariates (29 laboratory parameters at baseline, C1, and 13 clinical characteristics). The second, a combined predictive dataset, consists of 71 covariates, i.e. the 42 baseline covariates and a further 29 derived from the change in lab-based parameters between C1 and C2, measured by log fold change (LFC) of the variable of interest. Drug: 1 = patient was given Patritumab, 0 = drug was not given Age: Patient age in years at baselineSex: 1 = Female, 0 = MaleSite: one-hot encoded site of primary cancerPrev.Cetux: Cetuximab given previouslyHPV.status: 1 = positiveHereg.status: 1 = positiveSmoking: 2 = Current, 1 = Ex smoker, 0 = Never smoked